Table 3.
Healthy Controls | CA-LVEFp | CA-LVEFd | P | |
---|---|---|---|---|
LVEDV (mL/m2) | 70 ± 13 | 72 ± 14 | 83 ± 12 | 0.001 |
LVESV (mL/m2) | 21 ± 6 | 26 ± 6 | 38 ± 6 | < 0.001 |
LVEF (%) | 69 ± 6 | 65 ± 5 | 54 ± 3 | < 0.001 |
LVM (g/m2) | 68 ± 10 | 79 ± 13 | 84 ± 12 | < 0.001 |
RWM (g/mL) | 0.99 ± 0.15 | 1.10 ± 0.23 | 1.04 ± 0.19 | 0.003 |
LVH (n, % of subjects with LVH) | 0, 0 | 17, 28 | 11, 34 | 0.001 |
LGE (n, % of subjects with LGE) | 0, 0 | 18, 30 | 10, 33 | 0.001 |
LGE (gr) | 0 | 0.79 ± 0.18 | 0.89 ± 0.23 | 0.089 |
LGE (% of LV myocardium) | 0 | 0.54 ± 0.13 | 0.55 ± 0.13 | 0.265 |
RVEDV (mL/m2) | 73 ± 13 | 79 ± 15 | 87 ± 12 | 0.004 |
RVESV (mL/m2) | 28 ± 7 | 34 ± 9 | 41 ± 7 | < 0.001 |
RVEF (%) | 62 ± 6 | 58 ± 5 | 52 ± 4 | < 0.001 |
LV left ventricle, EDV end-diastolic volume, ESV end-systolic volume, EF ejection fraction, LVM left ventricular mass, RWM relative wall mass, LVH left ventricular hypertrophy, RV right ventricle